GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q3 2025
Top Holdings54 positions
CVS HEALTH CORP | 8.2M | $618M | 13.8% | $57.60 | +26.86% | 8 qtrssince 2023-Q4 | Unchanged 0 |
TENET HEALTHCARE CORP | 2.3M | $471.8M | 10.5% | $55.85 | +263.56% | 28 qtrssince 2018-Q4 | Decreased 0 |
GLOBAL PAYMENTS INC | 5.1M | $427.2M | 9.5% | $112.84 | -27.32% | 20 qtrssince 2020-Q4 | Increased 72 |
SPDR S&P 500 ETF TRUST | 566,700 | $377.5M | 8.4% | — | — | — | New — |
TEVA PHARMACEUTICAL IND LTD | 16.7M | $337.2M | 7.5% | $14.94 | +35.20% | 8 qtrssince 2023-Q4 | Increased 64 |
ZOOMINFO TECHNOLOGIES INC-A | 18.5M | $201.9M | 4.5% | $10.64 | +9.12% | 6 qtrssince 2024-Q2 | Increased 63 |
AMAZON.COM INC | 652,138 | $143.2M | 3.2% | $175.14 | +25.37% | 11 qtrssince 2023-Q1 | Increased 64 |
THERMO FISHER SCIENTIFIC INC | 282,941 | $137.2M | 3.1% | $455.17 | +6.18% | 2 qtrssince 2025-Q2 | Increased 89 |
DXC TECHNOLOGY CO | 8.3M | $113.7M | 2.5% | $25.91 | -47.40% | 28 qtrssince 2018-Q4 | Increased 69 |
UNIVERSAL HEALTH SERVICES-B | 482,169 | $98.6M | 2.2% | $162.37 | +9.23% | 12 qtrssince 2022-Q4 | Increased 62 |
PAYPAL HOLDINGS INC | 1.3M | $89.4M | 2.0% | $66.11 | -16.00% | 3 qtrssince 2025-Q1 | Increased 60 |
VIATRIS INC | 8.2M | $81.7M | 1.8% | $10.15 | -5.81% | 8 qtrssince 2023-Q4 | Unchanged 0 |
US FOODS HOLDING CORP | 1.1M | $81.6M | 1.8% | $44.08 | +73.83% | 16 qtrssince 2021-Q4 | Decreased 0 |
DICKS SPORTING GOODS INC | 351,601 | $78.1M | 1.7% | $195.80 | +10.45% | 2 qtrssince 2025-Q2 | Increased 56 |
EXPEDIA GROUP INC | 359,793 | $76.9M | 1.7% | $119.61 | +84.04% | 13 qtrssince 2022-Q3 | Decreased 0 |
ZILLOW GROUP INC - C | 889,666 | $68.5M | 1.5% | $80.54 | 0.00% | 1 qtr | New 68 |
ALIGHT INC | 20.4M | $66.4M | 1.5% | $7.54 | +24.07% | 13 qtrssince 2022-Q3 | Decreased 0 |
ICON PLC | 371,418 | $65M | 1.4% | $163.44 | +0.45% | 1 qtr | New 67 |
MARVELL TECHNOLOGY INC | 676,980 | $56.9M | 1.3% | $74.48 | +269.59% | 3 qtrssince 2025-Q1 | Increased 68 |
UNITED AIRLINES HOLDINGS INC | 582,009 | $56.2M | 1.3% | $74.17 | +30.10% | 3 qtrssince 2025-Q1 | Increased 47 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.5B across 54 positions as of Q3 2025. Top holdings: CVS (13.8%), THC (10.5%), GPN (9.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 17 new positions, 6 exits, 19 increased. Top move: TMO (INCREASED, conviction 89). Portfolio: $4.5B across 54 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR